Friends at Akaza,
We’re currently planning to upgrade from v2.2.1 to 3.0.
How will our ongoing studies be affected?
1. What will happen to existing meeting role assignments? Roles in 3.0 are quite different. (None of the studies has sites.)
2. Do we need to create new versions of any CRFs? I believe it was mentioned during the 28Oct09 webinar that v3.0 will support CRFs created under 2.5x and 2.2x, but some of the studies are still using some CRFs created under v1.x.
3. Are there any differences in study details that will need to be addressed?
4. What else should we be concerned with?
Cynthia S. Lassnoff, MS
Senior Systems Analyst / Business Analyst
HHS / NIH / NIAID / OCICB / SEB
(international +1) 301-841-4191, [email protected]
DISCLAIMER: The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's own and not expressly made on behalf of NIAID by one of its representatives.